Development of new antituberculosis drugs
By: W.W. Yew, editor.
Contributors: Yew, W. W.
Publisher: Nova Science Publishers
Published: 2006
Place of publication: New York
Language: eng
Subjects: Antitubercular agents.; Tuberculosis -- Chemotherapy.; Antitubercular Agents -- pharmacology.; Tuberculosis, Pulmonary -- drug therapy.; Drug Design.
Table of contents: title: Global control of tuberculosis and new drugs: public health aspects of new drug development for tuberculosis / Donald A. Enarson; title: Genomics in the fight against mycobacterial diseases / Antoine Danchin; title: Target selection to shorten the course of tuberculosis chemotherapy / Clifton E. Barry 3rd, Helena I.M. Boshoff and Laura E. Via; title: Pharmacological issues in the development of new antituberculosis drugs / Eric L. Nuermberger, Jacques H. Grosset and Charles A. Peloquin; title: The mouse model in evaluation of new antituberculosis drugs: promise and limitations / Michael H. Cynamon and John T. Welch; title: Surrogate markers to assess clinical efficacy of new antituberculosis drugs / Robert S. Wallis and John L. Johnson; title: Early bactericidal activity studies: promise and pitfalls / Stephen H. Gillespie; title: Role of clinical trials in the evaluation of new anti-tuberculosis drugs / Chi Chiu Leung and Cheuk Ming Tam; title: Current and future uses of rifamycins in the treatment of pulmonary tuberculosis / Andrew A. Vernon; title: Fluoroquinolones in the treatment of tuberculosis: current status and future issues / Wing Wai Yew, Chi Hung Chau and Michael D. Iseman; title: Management of latent tuberculosis infection today and in the future / Robert M. Jasmer and Charles L. Daley; title: Novel delivery systems for anti-tuberculosis drugs / Rajesh Pandey and Gopal K. Khuller; title: Immunology of tuberculosis: implications for the development of new therapies and vaccines / Graham A.W. Rook and Keertan Dheda.